Market research
T5O.F CytoTools AG
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 139K
- P/E ratio
- Not available
- Analyst target
- 3.1
- Dividend yield
- Not available
- Beta
- 1.24
Community
Investor discussion
1 comment
Sign in to join the T5O.F discussion.
5 years, 5 months ago
CytoTools AG is currently in a long term downtrend where the price is trading 9.8% below its 200 day moving average.
From a valuation standpoint, the stock is 3987.5% more expensive than other stocks from the Financial Services sector with a price to sales ratio of 1814.7.
Based on the above factors, CytoTools AG gets an overall score of 0/5.